Upadacitinib improves patient-reported outcomes vs placebo or adalimumab in patients with rheumatoid arthritis: results from SELECT-COMPARE

por Strand, Vibeke, Tundia, Namita, Bergman, Martin, Ostor, Andrew, Durez, Patrick, Song, In-Ho, Enejosa, Jeffrey, Schlacher, Casey, Song, Yan, Fleischmann, Roy
Publicado 2021